DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a large spike in volatility.
>>5 Hated Earnings Stocks You Should Love
Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.
>>5 Stocks Poised for Breakouts
With that in mind, let's take a look at several stocks rising on unusual volume today.
Top Quality Companies To Buy For 2015: Reed Elsevier NV (ENL)
Reed Elsevier NV offers professional information solutions in North America and Europe. The company�s Scientific, Technical & Medical segment publishes research, reference, and education content; and offers database and workflow solutions for scientists, research leaders and administrators, doctors, nurses, health professionals, and students, as well as hospitals, academic and research institutions, health insurers, managed healthcare organizations, research corporations, and governments. It also provides abstract and citation database of research literature; an oil and gas exploration tool that packages research-relevant geological content and tags that content to enable search functionality; and solutions for synthetic chemists. In addition, this segment offers software and tools that enhance research outcomes of academic institutions and researchers; and Web-based tools for the engineering community. Its Risk Solutions segment provides data and analytics to property an d casualty personal and commercial, and life insurance carriers; and risk and identity management, fraud detection, credit risk management, and compliance solutions for financial institutions, as well as offers risk-related information to the legal industry. The company�s Business Information segment provides data services, such as information and pricing services for the chemicals, fertilizers, and energy sectors; payment routing data and anti-money laundering services, as well as compliance information to the banking and corporate sectors; online regulatory guidance, practices, and tools for HR professionals; and online construction data and information to the construction industry. Its Legal segment offers legal, regulatory, news and business, and analysis services to legal, corporate, government, and academic customers. The company�s Exhibitions segment organizes exhibitions and conferences in various industries. Reed Elsevier NV was founded in 1903 and is based in Ams terdam, the Netherlands.
Advisors' Opinion:- [By David Hunkar]
Current Dividend Yield: 4.68%
Company: Reed Elsevier NV (ENL)
Sector: Electric Utilities
Country: PortugalCurrent Dividend Yield: 3.03%
Sector: Media
Country: The Netherlands - [By Vanina Egea]
Reed Elsevier NV (ENL) is a diversified publisher and information provider. It works on a wide range of market segments that include scientific, technical and medical (STM); legal; risks solutions and business information and exhibitions. The key of the company�� growth, however, lies almost exclusively in two brands: Elsevier and LexisNexis.
10 Best Stocks To Invest In 2014: Austin Engineering Ltd (ANG)
Austin Engineering Limited is engaged in the manufacture, repair, overhaul and supply of mining attachment products, general steelwork structures and other associated products and services for the industrial and resources-related business sectors. The Company operates in four segments: Australia, which includes mining equipment, other products and repair and maintenance services; Americas, which includes mining equipment and other products, consisting of North America and South America; Asia, which includes Indonesia for mining equipment and other products, and the Middle East, which includes aluminum smelter equipment and products. In October 2013, Austin Engineering Limited completed the acquisition of the business of Servigrut. Advisors' Opinion:- [By Julia Leite]
South African miners rallied after a recovery in gold prices. The FTSE/JSE Africa All-Share Index climbed 1.5 percent in Johannesburg, with Harmony Gold Mining Co. (HAR) and AngloGold Ashanti Ltd. (ANG) adding at least 5.2 percent.
10 Best Stocks To Invest In 2014: Star Bulk Carriers Corp.(SBLK)
Star Bulk Carriers Corp. operates as a shipping company providing seaborne transportation solutions in the dry bulk sector worldwide. Its vessels transport major bulks, which include iron ore, coal, and grain; and minor bulks, such as bauxite, fertilizers, and steel products. The company has an operating fleet of 15 dry bulk carriers consisting of 7 Capesize and 8 Supramax dry bulk vessels with a combined cargo carrying capacity of 1,625,945 deadweight tons. The company was incorporated in 2006 and is based in Athens, Greece.
Advisors' Opinion:- [By James E. Brumley]
It's certainly no Safe Bulkers, Inc. (NYSE:SB) or Star Bulk Carriers Corp. (NASDAQ:SBLK), in terms or market cap or revenue. In fact, even with the drybulk shipping industry it's a somewhat obscure name. Yet, FreeSeas Inc. (NASDAQ:FREE) may well be the stock with the most near-term potential upside, now that it's gotten over a key technical hump.
10 Best Stocks To Invest In 2014: Inteliquent Inc (IQNT)
Inteliquent Inc, formerly Neutral Tandem, Inc., doing business as Inteliquent, incorporated on April 19, 2001, provides solutions for voice, data, and hosted services globally. With over 120 Ethernet sites across four continents, the Company is a global Ethernet interconnection provider, and has an Internet protocol version 6 (IPv6) network. Inteliquent is a network solutions provider, offering intelligent networking to solve interconnection and interoperability issues on a global scale. With multiprotocol label switching (MPLS) network, which is interconnected to carriers globally, it provides voice, Internet protocol (IP) transit and Ethernet solutions to carriers, service providers, and content management firms based in over 80 countries, across six continents. Its IP Transit provides bandwidth for Internet service providers (ISP), mobile operators, Telcos, enterprises and content providers. In September 2012, it announced the establishment of its Turkish subsidiary, as well as its strategic alliance with Turkey's Turkcell Superonline. In April 2013, Neutral Tandem Inc acquired the global data services business of Global Telecom & Technology Inc.
The Company simplifies the complexities of data networking by making interconnection. Its EtherCloud transforms and simplifies the delivery of Ethernet and virtual private local area network (LAN) service (VPLS) services over a global footprint. A layer-II platform, EtherCloud connects partner networks into a seamless Ethernet cloud, which delivers end-to-end connectivity globally. It relies on Inteliquent�� global MPLS backbone as a distributed switched network, which is accessible in 120 point of purchases (PoPs) across four continents, to interconnect partners��networks through standardized external network-to-network interfaces (E-NNIs). By interconnecting partner networks to create one holistic Ethernet cloud, EtherCloud enables you to both source and to sell Ethernet and VPLS connectivity. It provides a one-stop-shop to conne! ct globally.
The Company provides a range of voice services. Inteliquent's voice services include streamlined session initiation protocol (SIP) interconnection options for domestic and international long distance traffic. It offers terminating and originating access, which supports billions of minutes of billable traffic each month. Its services include Access Homing Tandem and Gateway Tandem Services. It has the first wholesale, white-label hosted collaboration solution to be resold by value added resellers (VAR) and system integrators (SI). The hosted collaboration solution (HCS) offers a range of unified communication products and services, including single number reach, integrated messaging and presence, video calling, and WebEx integration.
Advisors' Opinion:- [By Rick Munarriz]
Briefly in the news
Shares of Chipotle Mexican Grill (NYSE: CMG ) hit a new 52-week high after posting stronger revenue than analysts were expecting. The burrito roller also indicated that menu price increases are on the way in a move that will increase margins. Netflix (NASDAQ: NFLX ) also landed a fresh 52-week high, but it doesn't report until next week. The big push for the leading video service was a dozen Emmy nominations for House of Cards and Arrested Development. There's always a model-affirming Emmy nod in the banana stand. Inteliquent (NASDAQ: IQNT ) moved sharply higher after jacking up its revenue and adjusted EBITDA targets for the year. The provider of wholesale voice services had hosed down its outlook in May.
And now let's take a quick look at some of the other stories that shaped our week. - [By The GeoTeam]
The largest single event the company has achieved is the acquisition of Tinet from Inteliquent (IQNT) , which had been IQNT's global data business. IQNT provides services to telecom providers, helping them deliver their network reach. With the divestiture of Tinet, IQNT's major focus is the delivery of voice versus data services.
10 Best Stocks To Invest In 2014: MiMedx Group Inc (MDXG)
MiMedx Group, Inc. (MiMedx), incorporated on February 28, 2008, is an integrated developer, manufacturer and marketer of regenerative biomaterial products processed from human amniotic membrane. The Company�� biomaterial platform technologies include the device technologies HydroFix and CollaFix, and tissue technologies, AmnioFix and EpiFix. Its tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through the Company�� donor program, mothers delivering full-term caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce a manipulated implant for homologous use. MiMedx is the supplier of amniotic tissue, having supplied over 100,000 implants to distributors and other equipment manufacturers (OEMs) for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.
The Company has three platform technologies. Its largest addressable market is in chronic wound care consisting of diabetic, venous and pressure ulcers. On January 5, 2011, the Company acquired all of the outstanding equity interests in Surgical Biologics, LLC. Located in Kennesaw, Georgia, Surgical Biologics develops allografts and other products processed from human amniotic membrane that can be used for a range of medical applications, including ocular surface repair, gum repair, wound care, nerve and tendon repair, spine repair, burn treatment, and many other types of procedures that require the repair of a patient�� integumental (native) tissue. Surgical Biologics has developed a specialized process for the processing of amniotic membrane to produce a manipulated allograft for homologous use.
AmnioFix and EpiFix
MiMedx is the supplier of allografts processed from amniotic tissue, having supplied over 70,000 allografts to date for application in the Ophthalm! ic, Orthopedic, Dental, Spinal and Wound Care segments of healthcare. Its amnion products, AmnioFix and EpiFix, are processed from human tissue. The AmnioFix and EpiFix allografts can be used for a range of procedures, including ocular surface repair, gingival recession repair, wound care, burns, and many other types of procedures for the repair of a patient�� integumental (native) tissue. Its AmnioFix technology also is used as a graft to reduce the amount of scar tissue formation, provide a local anti-inflammatory and help with the soft tissue healing of the area. EpiFix offers a range of wound healing and wound care options. Much of the clinical usage of EpiFix has been for wound care patients suffering from diabetic ulcers, pressure ulcers, vein circulation ulcers, or artery circulation ulcers.
CollaFix
The Company�� CollaFix technology combines a means of creating fibers from soluble collagen and a specialized cross-linking process. MiMedx utilizes two separate cross-linking technologies for various applications. Initial laboratory and animal testing shows that the cross-linked collagen fibers produce a biocompatible, and durable construct that can be transformed into surgical meshes intended to treat a number of orthopedic soft-tissue trauma and disease disorders.
HydroFix
The Company licenses rights to a polyvinyl alcohol (PVA) polymer, which is a water-based biomaterial that can be manufactured with a range of mechanical properties, including those that appear to mimic closely the mechanical and physical properties of natural, healthy human tissue. This hydrogel has been used in other orthopedic and general surgery device applications, and it has demonstrated biocompatibility and durability inside the human body. It has a similar version of the product for the European market called HydroFix Spine Shield. The device is classified as a post-surgical adhesion inhibiting barrier and is used in specific spine surgeries. In December the original! HydroFix! Spine Shield (for Anterior use Class IIb in Europe) was renamed to be HydroFix Anterior Shield.
The Company competes with W.L. Gore & Associates, Inc. and Stryker.
Advisors' Opinion:- [By Sean Williams]
What: Shares of MiMedx Group (NASDAQ: MDXG ) , a manufacturer of patented regenerative biomaterial products (in essence, products designed to treat inflammation and help wounds heal), were eviscerated, falling as much as 70% at one point before recovering half of its losses after it announced the receipt of an untitled letter from the Food and Drug Administration alleging it does not possess the proper licensing to manufacture certain products.
- [By Garrett Cook]
MiMedx Group (NASDAQ: MDXG) shares were also up, gaining 12.10 percent to $7.04 after the company reported Q2 earnings of $0.00 per share on revenue of $25.60 million and raised its FY14 sales outlook.
- [By Teresa Rivas]
The Securities and Exchange Commission charged Arrowood and Petit, CEO of MiMex Group (MDXG), in January of last year. The SEC alleges that Arrowood received non-public information about the potential sale of Matria Healthcare (a publicly traded company that merged with Inverness Medical Innovations in 2008) from Petit, who was CEO of the firm at that time.
10 Best Stocks To Invest In 2014: Portola Pharmaceuticals Inc (PTLA)
Portola Pharmaceuticals, Inc. (Portola), incorporated on September 2, 2003, is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.
Betrixaban
Portola's compound, betrixaban, is an oral, once-daily Factor Xa inhibitor being evaluated in the only biomarker-based Phase-III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's properties particularly suited to potentially demonstrate efficacy without increasing bleeding in this patient population.
Andexanet Alfa
Portola's second development candidate, andexanet alfa (PRT4445), has the potential to be a reversal agent to directly reverse the effects of Factor Xa inhibitors in patients who suffer a bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors, including Bristol-Myers Squibb and Pfizer (Eliquis [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO [rivaroxaban]), and Daiichi Sankyo (Savaysa [edoxaban]), while retaining all decision-making and commercial rights to the program.
Cerdulatinib (PRT2070) and PRT2607
Portola's third wholly owned product candidate, cerdulatinib (PRT2070), is an orally available kinase inhibitor that uniquely inhibits two validated tumor proliferation pathways - spleen tyrosine kinase (Syk) and janus kinase (JAK). It is being studied in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations. Portola's fourth program is partnered with Biogen Idec and is focused on the development of PRT2607, a selective Syk inhibitor.
Advisors' Opinion:- [By Todd Campbell]
That leads me to Medivation (NASDAQ: MDVN ) , Ophthotech (NASDAQ: OPHT ) , and Portola (NASDAQ: PTLA ) , three companies with important therapies that may very well be destined to become top sellers.
10 Best Stocks To Invest In 2014: Charter Communications Inc.(CHTR)
Charter Communications, Inc., through its subsidiaries, provides entertainment, information, and communications solutions to residential and commercial customers in the United States. The company offers cable video programming services, such as basic and digital video, premium channels, OnDemand, pay-per-view, high definition television, digital video recorder, and online video services; Internet services; Charter.net, which provides multiple e-mail addresses, as well as various entertainment, games, news, and sports content; and telephone services. It also provides broadband communications solutions, such as Internet access, data networking, fiber connectivity to cellular towers and office buildings, video entertainment services, and business telephone services under the Charter Business brand name to business and carrier organizations. As of December 31, 2011, the company served approximately 4.1 million video customers; approximately 3.5 million Internet customers; appr oximately 1.7 million telephone customers; and approximately 476,200 commercial primary service units. Charter Communications, Inc. was founded in 1999 and is based in St. Louis, Missouri.
Advisors' Opinion:- [By James Miller Phd]
The company has a current ratio of 13.05% which is higher than the one registered by Charter Communications Inc. (CHTR), Digital Globe Inc. (DGI), EchoStar Corp (SATS), Gilat Satellite Networks Ltd. (GILT) and Intelsat SA (I).
No comments:
Post a Comment